GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820.

Article  Google Scholar 

Lindley RI. Stroke prevention in the very elderly. Stroke. 2018;49:796–802.

Article  PubMed  Google Scholar 

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147:e93–621.

Article  PubMed  Google Scholar 

Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31:1240–9.

Article  PubMed  CAS  Google Scholar 

Sandercock P, Gubitz G, Foley P, Counsell C. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2003;2:CD000029.

Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86.

Article  Google Scholar 

Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility. Stroke. 2008;39:390–6.

Article  PubMed  Google Scholar 

Lipowski ZJ. Delirium (acute confusional states). JAMA. 1987;258:1789–92.

Article  PubMed  CAS  Google Scholar 

Carin-Levy G, Mead GE, Nicol K, Rush R, van Wijck F. Delirium in acute stroke: screening tools, incidence rates and predictors: a systematic review. J Neurol. 2012;259:1590–9.

Article  PubMed  CAS  Google Scholar 

Hénon H, Lebert F, Durieu I, Godefroy O, Lucas C, Pasquier F, et al. Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke. 1999;30:773–9.

Article  PubMed  Google Scholar 

Kostalova M, Bednarik J, Mitasova A, Dušek L, Michalcakova R, Kerkovsky M, et al. Towards a predictive model for post-stroke delirium. Brain Inj. 2012;26:962–71.

Article  PubMed  Google Scholar 

Mc Manus J, Pathansali R, Hassan H, Ouldred E, Cooper D, Stewart R, et al. The evaluation of delirium post-stroke. Int J Geriatr Psychiatry. 2009;24:1251–6.

Article  PubMed  Google Scholar 

Miu DK, Yeung JC. Incidence of post-stroke delirium and 1-year outcome. Geriatr Gerontol Int. 2013;13:123–9.

Article  PubMed  Google Scholar 

Sheng AZ, Shen Q, Cordato D, e Zhang YY, Yin Chan DK. Delirium within three days of stroke in a cohort of elderly patients. J Am Geriatr Soc. 2006;54:1192–8.

Article  PubMed  Google Scholar 

Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304:443–51.

Article  PubMed  CAS  Google Scholar 

Thingstad P, Askim T, Beyer MK, Bråthen G, Ellekjær H, Ihle-Hansen H, et al. The Norwegian cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study. BMC Neurol. 2018;18:193.

Article  PubMed  PubMed Central  Google Scholar 

Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, et al. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry. 2014;71:397–403.

Article  PubMed  CAS  Google Scholar 

Hatta K, Kishi Y, Wada K, Takeuchi T, Ito S, Kurata A, et al. Preventive effects of suvorexant on delirium: a randomized placebo-controlled trial. J Clin Psychiatry. 2017;78:e970–9.

Article  PubMed  Google Scholar 

Matsuoka A, Tobita S, Sogawa R, Shinada K, Murakawa-Hirachi T, Shimanoe C, et al. Evaluation of suvorexant and lemborexant for the prevention of delirium in adult critically ill patients at an advanced critical care center: a single-center, retrospective, observational study. J Clin Psychiatry. 2022;84:22m14471.

Article  PubMed  Google Scholar 

Bassetti CL. Sleep and stroke. Semin Neurol. 2005;25:19–32.

Article  PubMed  Google Scholar 

Machida I, Aoki T, Kohduki K, Kishi Y, Hoaka T. Development of delirium screening tool. Jpn J Gen Hosp Psychiatry. 2003;15:150–5. [in Japanese].

Google Scholar 

Hashimoto Y, Kano O, Ebihara S. Noise pareidolia test for predicting delirium in hospitalized older patients with cognitive decline. Geriatr Gerontol Int. 2022;22:883–8.

Article  PubMed  Google Scholar 

Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988;23:89–97.

Article  PubMed  CAS  Google Scholar 

European Association for the Study of the Liver. EASL Clinical Practice guidelines: drug-induced liver injury. J Hepatol. 2019;70:1222–61.

Article  Google Scholar 

Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179–84.

Article  PubMed  Google Scholar 

Saxena S, Lawley D. Delirium in the elderly: a clinical review. Postgrad Med J. 2009;85:405–13.

Article  PubMed  CAS  Google Scholar 

Schor JD, Levkoff SE, Lipsitz LA, Reilly CH, Cleary PD, Rowe JW, et al. Risk factors for delirium in hospitalized elderly. JAMA. 1992;267:827–31.

Article  PubMed  CAS  Google Scholar 

Spira AP, Gamaldo AA, An Y, Wu MN, Simonsick EM, Bilgel M, et al. Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013;70(12):1537–43.

PubMed  PubMed Central  Google Scholar 

Wu YC, Tseng PT, Tu YK, Hsu CY, Liang CS, Yeh TC, et al. Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis. JAMA Psychiatry. 2019;76:526–35.

Article  PubMed  PubMed Central  Google Scholar 

Hatta K, Kishi Y, Wada K, Takeuchi T, Hashimoto N, Suda K, et al. Real-world effectiveness of ramelteon and suvorexant for delirium prevention in 948 patients with delirium risk factors. J Clin Psychiatry. 2019;81:19m12865.

Article  PubMed  Google Scholar 

Watson PL, Ceriana P, Fanfulla F. Delirium: is sleep important? Best Pract Res Clin Anaesthesiol. 2012;26(3):355–66.

Article  PubMed  Google Scholar 

Chan CK, Song Y, Greene R, Lindroth H, Khan S, Rios G, et al. Meta-analysis of ICU delirium biomarkers and their alignment with the NIA-AA Research Framework. Am J Crit Care. 2021;30(4):312–9.

Article  PubMed  PubMed Central  Google Scholar 

Cho JH, Bhutani S, Kim CH, Irwin MR. Anti-inflammatory effects of melatonin: a systematic review and meta-analysis of clinical trials. Brain Behav Immun. 2021;93:245–53.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–49.

Article  PubMed  PubMed Central  Google Scholar 

Albrecht S, Ihmsen H, Hering W, Geisslinger G, Dingemanse J, Schwilden H, et al. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther. 1999;65:630–9.

Article  PubMed  CAS  Google Scholar 

Ishibashi Y, Nishitani R, Shimura A, Takeuchi A, Touko M, Kato T, et al. Non-GABA sleep medications, suvorexant as risk factors for falls: case-control and case-crossover study. PLoS ONE. 2020;15(9):e0238723.